NEW YORK — As the U.S. flu season winds down, health officials say the flu vaccine didn’t work very well, with one of its worst effectiveness rates in more than a decade. A new strain that dominated ...

For the past week, about 50 flu scientists from around the world were crammed into a conference room at a Hilton hotel in Istanbul, Turkey. Their goal was to design a flu shot that will confer the ...

Kendra Pierre-Louis: For Scientific American’s Science Quickly, I’m Kendra Pierre-Louis, in for Rachel Feltman. You’re listening to our weekly science news roundup. Let’s start off with a vaccine 180.

WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

Moderna said the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing an earlier decision to refuse to accept the application. The FDA is slated to make a ...

The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said ...

The U.S. Food and Drug Administration has reversed course and will review a new mRNA flu vaccine from Moderna, the pharmaceutical company said Wednesday.About two weeks ago, the FDA sent Moderna a ...

The Food and Drug Administration has reversed its decision not to review a new flu vaccine from Moderna, the pharmaceutical company said Wednesday. Last week, the FDA sent a missive to Moderna ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The compromise clears a path for ...